Document is current
Any future updates will be listed below
-
Authors
Luyt, Charles-Edouard http://orcid.org/0000-0001-7424-2705
Sahnoun, Tarek
Gautier, Melchior
Vidal, Pauline
Burrel, Sonia
Pineton de Chambrun, Marc
Chommeloux, Juliette
Desnos, Cyrielle
Arzoine, Jeremy
Nieszkowska, Ania
Bréchot, Nicolas
Schmidt, Matthieu
Hekimian, Guillaume
Boutolleau, David
Robert, Jérôme
Combes, Alain
Chastre, Jean
- License Information
-
More Information
Article History
Received: 3 August 2020
Accepted: 13 November 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: In accordance with the current French law, informed written consent for demographic, physiologic and hospital-outcome data analyses was not obtained because this observational study did not modify existing diagnostic or therapeutic strategies. Nonetheless, patients and/or relatives were informed about the anonymous data collection and told that they could decline inclusion. The protocol was approved by our institution’s ethics committee (CER-Sorbonne Université, no. CER-SU-2020-46) and the database is registered with the Commission Nationale l’Informatique et des Libertés (CNIL, registration no. 1950673).
: Not applicable.
: C.-E. L. has served as consultant for Bayer Healthcare, Carmat and Thermo Fisher Brahms, and received lecture fees from MSD, Aerogen and BioMérieux, outside the submitted work. The other authors have no conflicts of interest to declare in relationship to this manuscript.
